| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JXHL1800173 | Baricitinib (LY3009104)口服混悬液 | baricitinib | Suspension | Chemical Drugs(2.2;2.4) | Import Drug Application | 2018-12-06 | Eli Lilly and Company | Eli Lilly & Company | In Review | 2018-12-05 | view |